Competition Office fines Biovit Pharma for false advertising
Hungary's Competition Office (GVH) on Tuesday said it had fined Biovit Pharma Kft Ft 2 million for false advertising.
The GVH said Biovit Pharma had made unsubstantiated claims about the effects of its "VigRX for Men" product.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.